Biotech Stocks: Analyst Downgrades Weigh On Drug Stocks

Shares of Regeneron, Curis and Endo Pharmaceuticals are falling in early trading following analyst downgrades.

BING NEWS:
  • William Blair downgrades Applied Therapeutics on revenue uncertainty
    William Blair downgraded Applied Therapeutics (APLT) to Market Perform from Outperform without a price target While the management turnover ...
    12/22/2024 - 10:05 pm | View Link
  • Stifel downgrades Biogen on slow Alzheimer’s drug launch, uncertainty ahead
    Stifel downgraded Biogen Inc (NASDAQ:BIIB) stock to “hold” from “buy” as it noted the company was grappling with a challenging year due to a slow rollout of its Alzheimer’s drug, lecanemab. Despite ...
    12/16/2024 - 6:06 am | View Link
  • BioAge Stock Nosedives On Obesity Drug Study Halt: Downgrades Crush Retail Sentiment
    BioAge Labs’ stock lost more than two-thirds of its market cap in pre-market trading Monday, poised to hit an all-time low following its decision to discontinue the STRIDES Phase 2 study of azelaprag, ...
    12/9/2024 - 12:28 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News